TY - JOUR
T1 - Diabetic endothelial dysfunction
T2 - Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation
AU - Soriano, Francisco
AU - Virág, László
AU - Szabó, Csaba
N1 - Funding Information:
Acknowledgements This work was supported by the following grant from the National Institutes of Health: R01GM60915 to C.S. L.V. was supported by a Bolyai Fellowship from the Hungarian Academy of Sciences and F.G.S. was supported by a FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil) research fellowship.
PY - 2001
Y1 - 2001
N2 - Peroxynitrite and hydroxyl radicals are potent initiators of DNA single-strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP ribose) polymerase (PARP). In response to high glucose incubation medium in vitro, or diabetes and hyperglycemia in vivo, reactive nitrogen and oxygen species generation occurs. These reactive species trigger DNA single-strand breakage, which induces rapid activation of PARR PARP in turn depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport, and ATP formation. This process results in acute endothelial dysfunction in diabetic blood vessels. Accordingly, inhibitors of PARP protect against endothelial injury under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP activation, PARP also appears to modulate the course of inflammation by regulating the activation of nuclear factor κB, and the expression of a number of genes, including the gene for intercellular adhesion molecule 1 and the inducible nitric oxide synthase. The research into the role of PARP in diabetic vascular injury is now supported by novel tools, such as new classes of potent inhibitors of PARP and genetically engineered animals lacking the gene for PARR Pharmacological inhibition of PARP emerges as a potential approach for the experimental therapy of diabetic vascular dysfunction.
AB - Peroxynitrite and hydroxyl radicals are potent initiators of DNA single-strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP ribose) polymerase (PARP). In response to high glucose incubation medium in vitro, or diabetes and hyperglycemia in vivo, reactive nitrogen and oxygen species generation occurs. These reactive species trigger DNA single-strand breakage, which induces rapid activation of PARR PARP in turn depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport, and ATP formation. This process results in acute endothelial dysfunction in diabetic blood vessels. Accordingly, inhibitors of PARP protect against endothelial injury under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP activation, PARP also appears to modulate the course of inflammation by regulating the activation of nuclear factor κB, and the expression of a number of genes, including the gene for intercellular adhesion molecule 1 and the inducible nitric oxide synthase. The research into the role of PARP in diabetic vascular injury is now supported by novel tools, such as new classes of potent inhibitors of PARP and genetically engineered animals lacking the gene for PARR Pharmacological inhibition of PARP emerges as a potential approach for the experimental therapy of diabetic vascular dysfunction.
KW - Cytokine
KW - Diabetes vascular
KW - Free radicals
KW - Nitric oxide
KW - Oxidants
UR - http://www.scopus.com/inward/record.url?scp=0034890040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034890040&partnerID=8YFLogxK
U2 - 10.1007/s001090100236
DO - 10.1007/s001090100236
M3 - Article
C2 - 11511974
AN - SCOPUS:0034890040
SN - 0946-2716
VL - 79
SP - 437
EP - 448
JO - Journal of Molecular Medicine
JF - Journal of Molecular Medicine
IS - 8
ER -